123 related articles for article (PubMed ID: 21293292)
1. Antiplatelet agents do not impact the hospital course in patients with gastrointestinal bleeding.
John BK; Arramraju S; Shalomov A; Sison C; Rubin M
J Clin Gastroenterol; 2011 Aug; 45(7):583-9. PubMed ID: 21293292
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
3. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
4. Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel.
Alli O; Smith C; Hoffman M; Amanullah S; Katz P; Amanullah AM
J Clin Gastroenterol; 2011; 45(5):410-4. PubMed ID: 20975574
[TBL] [Abstract][Full Text] [Related]
5. Do nonsteroidal anti-inflammatory drugs affect the outcome of patients admitted to hospital with lower gastrointestinal bleeding?
Yong D; Grieve P; Keating J
N Z Med J; 2003 Jul; 116(1178):U517. PubMed ID: 12897885
[TBL] [Abstract][Full Text] [Related]
6. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Delaney JA; Opatrny L; Brophy JM; Suissa S
CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Schreiner GC; Laine L; Murphy SA; Cannon CP
Crit Pathw Cardiol; 2007 Dec; 6(4):169-72. PubMed ID: 18091407
[TBL] [Abstract][Full Text] [Related]
8. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
9. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal bleeding after percutaneous coronary intervention.
Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
[TBL] [Abstract][Full Text] [Related]
11. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.
Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
Gastrointest Endosc; 2014 Dec; 80(6):1124-31. PubMed ID: 25088922
[TBL] [Abstract][Full Text] [Related]
12. Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy.
Singh M; Mehta N; Murthy UK; Kaul V; Arif A; Newman N
Gastrointest Endosc; 2010 May; 71(6):998-1005. PubMed ID: 20226452
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
[TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
17. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
20. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.
Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2014 Oct; 29(10):1786-93. PubMed ID: 24720424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
